Compugen Ltd. (TLV:CGEN)
533.00
-10.90 (-2.00%)
Feb 5, 2026, 5:27 PM IDT
Compugen Employees
Compugen had 74 employees as of December 31, 2024. The number of employees increased by 6 or 8.82% compared to the previous year.
Employees
74
Change (1Y)
6
Growth (1Y)
8.82%
Revenue / Employee
308.87K ILS
Profits / Employee
-1.24M ILS
Market Cap
503.86M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 74 | 6 | 8.82% |
| Dec 31, 2023 | 68 | -1 | -1.45% |
| Dec 31, 2022 | 69 | -4 | -5.48% |
| Dec 31, 2021 | 73 | 5 | 7.35% |
| Dec 31, 2020 | 68 | 7 | 11.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 117 |
| Bonus BioGroup | 37 |
| BioLineRx | 28 |
| Matricelf | 12 |
| XTL Biopharmaceuticals | 10 |
| Purple Biotech | 9 |
| Can-Fite BioPharma | 5 |
| BioLight Life Sciences | 4 |
Compugen News
- 4 weeks ago - Compugen (CGEN): HC Wainwright Initiates Coverage with 'Buy' Rating | CGEN Stock News - GuruFocus
- 7 weeks ago - Compugen rises on royalty deal with AstraZeneca - Seeking Alpha
- 7 weeks ago - AstraZeneca (AZN) and Compugen Partner to Monetize Royalties on Novel Therapy - GuruFocus
- 7 weeks ago - Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million - PRNewsWire
- 3 months ago - Compugen Ltd (CGEN) Q3 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - GuruFocus
- 3 months ago - Q3 2025 Compugen Ltd Earnings Call Transcript - GuruFocus
- 3 months ago - Compugen Ltd. (CGEN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Compugen (CGEN) Reports Q3 Loss, Lags Revenue Estimates - Nasdaq